The investment will accelerate the scale-up of Nano’s platform to expand vaccine access and alternate delivery
.
AUSTIN, Texas and DUBAI, UAE (Arab Newswire) Nano Cures Inc. (“
Nano”), clinical-stage biotechnology and infectious disease immunity platform company, announced a $90M pre-IPO funding round. The investment will be led by a $20M commitment from Opulence Capital Management, a Dubai-based private investment fund, with existing and new investors participating.
The investment will accelerate the global scale-up of Nano’s Cures Platform for Covid-19 variants, including vaccines and persistent immunity delivery. Nano’s novel self-administered technology moves delivery beyond syringes and shots, to an array of nasal, dermal, ophthalmic, sublingual, and oral options. Nano will open up its Cures Platform to other pharmaceutical companies and their vaccines, providing dynamic new ways to conquer the pandemic and deliver billions of doses directly to those in need.
/PRNewswire/ Nano Cures Inc. ("Nano"), a clinical stage biotechnology and infectious disease immunity platform company, today announced a $90M pre-IPO.
POLITICO
Get the POLITICO Influence newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by the Standing Rock Sioux Tribe and Earthjustice
With Daniel Lippman
PROGRAMMING NOTE: POLITICO Influence will not publish on Monday, Feb. 15. We ll be back on our normal schedule on Tuesday, Feb. 16.
NEW BUSINESS: Cloud computing giant Salesforce has added